Skip to main content
Patient Tammy
Patient Clyde
Patient Vaughn
Patient Brian
Patient Daniel
Patient Eric
Patient Patricia

Meet Team Novo8™.

Different backgrounds. Different Stories. One mission.

They come from all walks of life. Their mission is the same: to share their inspirational stories of living with hemophilia A and what Novo Nordisk's commitment to the hemophilia community has meant to them. Click on each team member to learn about his or her story.

Individual results may vary.

  • Meet Tammy

    Tammy was diagnosed with hemophilia A at the age of 5 when her father, who had hemophilia, noticed some familiar symptoms in her. At the time, there was little knowledge about hemophilia in girls, so her bruises and joint bleeds were not recognized as signs of a bleeding disorder. As an adult, Tammy was often told it was impossible for a woman to have hemophilia A—and when her son was born, this lack of awareness led to complications. Tammy made it her mission to promote awareness of hemophilia in women so others would not face roadblocks to treatment. Today, Tammy runs a non-profit for women with bleeding disorders. She also became a yoga therapist, with the intention of bringing yoga to the bleeding disorders community.

  • Meet Clyde

    Clyde was diagnosed with severe hemophilia A at birth. Growing up, he felt different, and all he wanted was to be like other kids. He attended hemophilia camps but reached a point where he no longer wished to be involved in the community—until he reached college age, when he realized that hemophilia is part of who he is. He embraced his bleeding disorder and became active with the hemophilia community. With 2 nephews who also live with hemophilia, Clyde strives to provide a good example by taking care of himself. He encourages his nephews and others living with hemophilia to take advantage of opportunities to have fun and just be themselves while managing their bleeding disorder.

  • Meet Vaughn

    Vaughn was diagnosed with mild hemophilia A at 18 months old. Growing up, his energetic and curious personality was a challenge because hemophilia limited his activities and left him feeling like he was “bubble-wrapped”.  Hemophilia treatment was different when Vaughn was young and his treatments often took 8 hours a day at the hospital. As a teenager, he contracted HIV from contaminated products and was told he had less than 2 years to live.  Although initially shaken by this news, Vaughn is not one to quit and now has his conditions under control.  As an adult, Vaughn is passionate about staying fit through diet and exercise as well as sharing his story with the world.  He also values a treatment that he can take with him as he lives his life.

  • Meet Brian

    Brian was diagnosed with hemophilia A at an early age. Because of the great support from the staff at his hemophilia treatment center, he learned how to be cautious while remaining very active. Throughout his life, Brian hasn't allowed hemophilia to limit his love of outdoor activities. Attending conferences, camps, and other hemophilia community events has also expanded his network of support and friendship. Brian's mission is to speak with families about his experiences living with hemophilia to remind them that they are not alone.

  • Meet Daniel

    Daniel was diagnosed with severe hemophilia A at 5 months. As a boy, he learned that having hemophilia didn't have to be awkward; that most people would treat him the same as anyone else. To further encourage Daniel to take control of his condition, his mother, Patricia, actively supported his desire to play sports. Daniel understands the challenges of transitioning into adulthood while living with hemophilia. His mission is to speak to young children and teenagers about how to deal with the challenges of growing up with hemophilia.

Patient Eric George, hands on hips

Meet Eric

Eric George was diagnosed with hemophilia A when he was born. Growing up in a family with 4 siblings who all have hemophilia taught him that the condition doesn't have to be a negative experience or stop you from achieving goals. In fact, he built a strong network around himself in the hemophilia community and he believes in the power of sharing experiences. His mission is to help others with bleeding disorders learn how to push past their challenges.

Individual results may vary.

Patricia

Meet Patricia

My son Daniel was born and diagnosed with severe hemophilia A. He is my third child and the only one with hemophilia; my daughter is a carrier as well. When Daniel was born, I felt very isolated. I had no good information and didn’t know anyone else dealing with hemophilia. Since then, I became involved with our local hemophilia chapter and that really helped us over the years to learn how to manage his disease.

Individual results may vary.

  • Playing It Safe

    This brochure from the National Hemophilia Foundation provides information on sports and activities and how your patients may participate safely in physical activities.

Selected Important Safety Information

Contraindications

  • Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins

Warnings and Precautions

  • Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment

Indications and Usage

Novoeight® (antihemophilic factor, recombinant) is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.

  • Novoeight® is not indicated for the treatment of von Willebrand disease

Important Safety Information

Contraindications

  • Do not use in patients who have had life-threatening hypersensitivity reactions, including anaphylaxis, to Novoeight® or its components, including hamster proteins

Warnings and Precautions

  • Anaphylaxis and severe hypersensitivity reactions are possible. Patients may develop hypersensitivity to hamster proteins, which are present in trace amounts in the product. Should symptoms occur, discontinue Novoeight® and administer appropriate treatment
  • Development of activity-neutralizing antibodies (inhibitors) may occur. Previously untreated patients (PUPs) are at greatest risk for inhibitor development with all factor VIII products. Inhibitors have been reported following administration of Novoeight in PUPs. If expected plasma factor VIII activity levels are not attained, or if bleeding is not controlled with an appropriate dose, perform testing for factor VIII inhibitors

Adverse Reactions

  • The most frequently reported adverse reactions (≥1%) were inhibitors in Previously Untreated Patients (PUPs), injection site reactions, and pyrexia.

Please click here for Prescribing Information.